Synergy CHC (SNYR): Operating Profitability

Corporate company logo of Synergy CHC Corp. (SNYR)

Synergy CHC Corp fully delegates product manufacturing to third-party enterprises while maintaining strict quality oversight. The team relies on creative e-commerce specialists supported by a flexible incentive system. Operating profit margins demonstrate efficiency dynamics, with the parameter stabilizing at -39.60. High growth potential is driven by a development model that avoids capital expenditures on factories.

SNYR: Synergy CHC Corp Operating Profitability Margin 10/24/2024 - 10/03/2026

Synergy CHC Corp. - analytical breakdowns and key metrics (SNYR)

- share price and consensus valuation forecast:
Comprehensive company analysis:Synergy CHC Corp., SNYR
Brand item of Synergy CHC

Synergy CHC Corp. (SNYR) maintains a diversified brand portfolio within the beauty and health sector, which stabilizes the profit share from core operations even amidst fluctuations in retail demand. This metric is calculated as the ratio of operating profit to revenue, measuring cost management efficiency before taxes and interest, thereby helping investors distinguish sustainable profitability growth from short-term market spikes.

Competitor analysis for Synergy CHC Corp

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.